| Literature DB >> 28178190 |
Tingting Tan1, Di Wu2, Weizhong Li3, Xin Zheng4, Weifen Li5, Anshan Shan6.
Abstract
Hybrid peptides integrating different functional domains of peptides have many advantages, such as remarkable antimicrobial activity, lower hemolysis and ideal cell selectivity, compared with natural antimicrobial peptides. FV7 (FRIRVRV-NH₂), a consensus amphiphilic sequence was identified as being analogous to host defense peptides. In this study, we designed a series of hybrid peptides FV7-LL-37 (17-29) (FV-LL), FV7-magainin 2 (9-21) (FV-MA) and FV7-cecropin A (1-8) (FV-CE) by combining the FV7 sequence with the small functional sequences LL-37 (17-29) (LL), magainin 2 (9-21) (MA) and cecropin A (1-8) (CE) which all come from well-described natural peptides. The results demonstrated that the synthetic hybrid peptides, in particular FV-LL, had potent antibacterial activities over a wide range of Gram-negative and Gram-positive bacteria with lower hemolytic activity than other peptides. Furthermore, fluorescent spectroscopy indicated that the hybrid peptide FV-LL exhibited marked membrane destruction by inducing outer and inner bacterial membrane permeabilization, while scanning electron microscopy (SEM) and transmission electron microscopy (TEM) demonstrated that FV-LL damaged membrane integrity by disrupting the bacterial membrane. Inhibiting biofilm formation assays also showed that FV-LL had similar anti-biofilm activity compared with the functional peptide sequence FV7. Synthetic cationic hybrid peptides based on FV7 could provide new models for combining different functional domains and demonstrate effective avenues to screen for novel antimicrobial agents.Entities:
Keywords: FV7; amino acid; antimicrobial peptide; biofilm; microbiology
Mesh:
Substances:
Year: 2017 PMID: 28178190 PMCID: PMC5343874 DOI: 10.3390/ijms18020339
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Three-dimensional structure projections of peptides and the process of hybrid peptide formation. FV7 is yellow, the helix model of the core sequences from native peptide (LL37, magainin 2 and cecropin A) is red.
Amino acid sequences, design, molecular weights, net charges and hydrophobicity values of the peptides used in this study.
| Peptide | Sequence | Design 1 | Theoretical Mw | Measured Mw 2 | Charge | H 3 |
|---|---|---|---|---|---|---|
| FV7 | FRIRVRV-NH2 | FV7 | 945.18 | 946.24 | +4 | 0.57 |
| LL | FKRIVQRIKDFLR-NH2 | LL-37 (17–29) | 1719.106 | 1718.14 | +4 | 0.46 |
| MA | AKKFGKAFVGEIM-NH2 | magainin 2 (9–21) | 1425.749 | 1424.78 | +2 | 0.53 |
| CE | KWKLFKKI-NH2 | cecropin A (1–8) | 1090.405 | 1089.45 | +4 | 0.50 |
| FV-LL | FRIRVRV-FKRIVQRIKDFLR-NH2 | FV7 + LL-37 (17–29) | 2646.27 | 2645.31 | +7 | 0.50 |
| FV-MA | FRIRVRV-AKKFGKAFVGEIM-NH2 | FV7 + magainin 2 (9–21) | 2352.92 | 2351.96 | +5 | 0.55 |
| FV-CE | FRIRVRV-AKKFGKAFVGEIM-NH2 | FV7 + cecropin A (1–8) | 2017.58 | 2016.62 | +7 | 0.53 |
1 Design refers to the composition of hybrid peptides; 2 Molecular weight (MW) was measured by mass spectroscopy (MS); 3 The relative hydrophobic moment (μHrel) of a peptide is its hydrophobic moment relative to that of a perfectly amphiphilic peptide. This gives a better idea of the amphiphilicity using different scales. A value of 0.5 thus indicates that the peptide has ~50% of the maximum possible amphiphilicity.
Figure 2The circular dichroism (CD) spectra of the peptides in 10 mM phosphate-buffered saline (PBS; pH 7.4) (●), 30 mM sodium dodecyl sulfate (SDS) (▪) and 50% trifluoroethyl alcohol (TFE) (▲). The peptide concentration was fixed at 150 μM.
Antibacterial activities of the peptides.
| MIC 1 (μM) | ||||||||
|---|---|---|---|---|---|---|---|---|
| FV7 | LL | MA | CE | FV-LL | FV-MA | FV-CE | ME26 | |
| 16 | 16 | 32 | 64 | 1 | 8 | 2 | 2 | |
| 32 | 16 | >64 | >64 | 4 | 8 | 2 | 2 | |
| 16 | 8 | >64 | >64 | 4 | 8 | 2 | 2 | |
| 32 | 16 | >64 | >64 | 2 | 2 | 2 | 2 | |
| 16 | 32 | >64 | >64 | 2 | 4 | 4 | 4 | |
| 32 | 16 | >64 | >64 | 2 | 4 | 4 | 4 | |
| 64 | 16 | >64 | >64 | 2 | 8 | 8 | 8 | |
| 32 | 32 | >64 | >64 | 4 | 16 | 1 | 1 | |
| 16 | 16 | >64 | >64 | 4 | 4 | 1 | 1 | |
| 32 | 8 | >64 | >64 | 1 | 8 | 0.5 | 0.5 | |
1 Minimum inhibitory concentrations (MIC) were determined as the lowest concentration of the peptides that inhibited bacteria growth. The tests were performed at least three times in duplicate.
Figure 3Hemolytic activities of the peptides against fresh human erythrocytes. The release of hemoglobin was monitored with a Microplate Autoreader (SpectraMax M5, Molecular Devices, San Francisco, CA, USA) by measuring the absorbance at 570 nm. Data are the averages of three independent experiments.
MIC values of peptides in the presence of physiological salts and heat with E. coli ATCC 25922 and S. aureus ATCC 29213.
| Peptide | Control 1 | NaCl 2 | KCl 2 | NH4Cl 2 | MgCl2 2 | ZnCl2 2 | FeCl3 2 | CaCl2 2 | Mix 3 | Heat (100 °C) |
|---|---|---|---|---|---|---|---|---|---|---|
| FV7 | 16 | 32 | 64 | >128 | 32 | 32 | 128 | 64 | 128 | 16 |
| FV-LL | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| FV-MA | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 16 |
| FV-CE | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 2 | 2 |
| ME26 | 2 | 4 | 2 | 2 | 4 | 4 | 2 | 2 | 4 | 2 |
| FV7 | 64 | 128 | 64 | 64 | 64 | 32 | 64 | 64 | 128 | 64 |
| FV-LL | 2 | 2 | 2 | 2 | 4 | 2 | 4 | 2 | 4 | 2 |
| FV-MA | 8 | 32 | 8 | 8 | 8 | 8 | 8 | 16 | 16 | 8 |
| FV-CE | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 4 | 4 |
| ME26 | 8 | 4 | 4 | 2 | 2 | 2 | 2 | 4 | 4 | 8 |
1 Minimum inhibitory concentrations (MICs) were texted as the lowest concentration of the peptides that inhibited bacteria growth; 2 The final concentrations of NaCl, KCl, NH4Cl, MgCl2, CaCl2, ZnCl2, and FeCl3 were 150, 4.5, 6, 1, 2.5, 8, and 4 mM, respectively, and the control MIC values were determined in the absence of these physiological salts; 3 The mixture medium contained all kinds of salts in physiological concentrations.
Figure 4The outer membrane permeability of the parental and hybrid peptides.
Figure 5The inner membrane permeability of the peptides. The hydrolysis of o-Nitrophenyl-β-d-galactopyranoside (ONPG) due to release of cytoplasmic β-galactosidase of E. coli UB1005 treated by 1× MIC peptides was measured spectroscopically at absorbance of 420 nm as a function of time.
Figure 6Scanning electron microscopy (SEM) micrographs of E. coli ATCC 25922 and S. aureus ATCC 29213 cells treated with peptides at their 1× MICs at about 1 h. E. coli ATCC 25922: (A) Control; (B) FV-LL; (C) FV-MA; (D) FV-CE. S. aureus ATCC 29213; (E) Control; (F) FV-LL; (G) FV-MA; (H) FV-CE. The control did not contain the peptides.
Figure 7Transmission electron microscopy (TEM) micrographs of E. coli ATCC 25922 and S. aureus ATCC 29213 cells treated with the peptides at their 1× MICs at about 1 h. E. coli ATCC 25922: (A) Control; (B) FV-LL; (C) FV-MA; (D) FV-CE. S. aureus ATCC 29213: (E) Control; (F) FV-LL; (G) FV-MA; (H) FV-CE. The control did not contain the peptides.
Figure 8Anti-biofilm activity of the peptides. The viability of P. aeruginosa PAO1 biofilm was reduced after 24-h treatment at higher concentrations of FV7 and FV-LL. The test was performed at least four times in triplicate.